The Framingham pharmaceutical firm Alzheon has partnered with the Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences to develop a diagnostic assay to measure substances believed to be neurotoxic drivers of Alzheimer’s disease pathology.
Блинкен прибывает в Украину с двухдневным визитом « Русский Еврей rusjev.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from rusjev.net Daily Mail and Mail on Sunday newspapers.
Look small, find large: from cellular biology to neurodegenerative diseases
Tomáš Knedlík works on mitochondria and their communication with other cell organelles. It is important to study mitochondria and their contacts because their dysfunction may lead to quite a number of disorders, such as Parkinson’s and Alzheimers’ diseases.
Tomáš obtained his PhD at the Institute of Organic Chemistry and Biochemistry in Prague, Czechia, and in 2019 he came to the University of Padua to work with Professor Giacomello at the Department of Biology. In 2020 he received a MSCA Individual Fellowship to support his project here.
Can you tell us in brief what your MSCA IF research project is about? Who will benefit from it?
Alzheon Partners with Czech Institute of Organic Chemistry and Biochemistry to Develop First Alzheimer’s Diagnostic Assay for Measuring Neurotoxic Beta Amyloid Oligomers in Human Brain - read this article along with other careers information, tips and advice on BioSpace
Ученые синтезировали эффективные соединения для противораковых препаратов ria.ru - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from ria.ru Daily Mail and Mail on Sunday newspapers.